Table 2.
Final PAS cost estimation model.
| Per Subject Cost | Per Site Cost | Study Overhead | Notes: | |||||
|---|---|---|---|---|---|---|---|---|
| Base Case: | Assumes a 2yr observational follow up of existing study cohort, with one phone evaluation per year | $600 | $2,800 | $400,000 | ||||
| Adjustments: | Need to Recruit Subjects | $2,600 | $3,250 | $325,000 | De novo cohort required | |||
| Adding a control group (1:1) | $325 | $406 | $40,625 | Due to complexity of recruiting patients to two therapies | ||||
| Requiring Randomization | $1,300 | $1,625 | $162,500 | |||||
| Additional Phone evaluations per year | $28 | $129 | $- | Per additional phone interview per year | ||||
| In-Person clinical evaluations | $138 | $644 | $- | Per additional in-person clinical evaluation per year | ||||
| Imaging study required | $1,000 | $250 | $50,000 | Examples: Chest CT, renal ultrasound, echocardiogram | ||||
| Required invasive study | $2,000 | $500 | $100,000 | Examples: coronary angiography, EGD, ERCP | ||||
| Extending additional year (w/ one eval per year) | $198 | $924 | $264,000 | Per year costs | ||||
| Large Study Adjustments: | ||||||||
| Overhead Costs for >1000 subjects | $- | $- | $200,000 | Per 1000 additional subjects | ||||
| Overhead Costs for >100 sites | $- | $- | $300,000 | Per 100 additional sites | ||||
| Reduced base-case cost if OUS sites | $480 | $2,240 | $320,000 | Based on proportion of study performed OUS | ||||
| Discount for non CV Organ system device study | $(120) | $(560) | $(80,000) | |||||